Simon Nyarko

Mr. Simon Nyarko

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2026 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
SNSimon Nyarko
Simon Nyarko
RARoger A. Atinga
Roger A. Atinga
DBDennis Bardoe
Dennis Bardoe
AOAbigail N. Owusu
Abigail N. Owusu
Digital health systems are increasingly central to health system performance, yet many low- and middle-income countries continue to struggle with integrati

15 January 2026 in The Journal of Environment & Development
Verified
Journal Article
Closed access
JMJames Kwame Mensah
James Kwame Mensah
SNSimon Nyarko
Simon Nyarko
PAPius Akoneke
Pius Akoneke
This systematic review examines the role of the circular economy (CE) in promoting sustainable urban development in Ghanaian cities. Using a Boolean search, 20 peer-reviewed articles, reports, and policy documents were analyzed from Scopus, ScienceDirect, DOAJ, AJOL, and Google Scholar. Grounded in the sustainable city nexus, the review identifies resource efficiency and waste management, renewable energy integration, sustainable urban planning and design, community engagement and education, and green and blue infrastructure as key characteristics of CE in Ghanaian cities. Despite progress, challenges persist, including inadequate infrastructure, low recycling rates, limited public awareness, fragmented governance, and poorly managed end-of-life waste. The review advances a holistic understanding of CE, proposes a framework for policymakers, and highlights opportunities for cross-sector collaboration and context-driven interventions.

7 February 2024 in Advances in Pharmacological and Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
SNSimon Nyarko
Simon Nyarko
KOKwabena Ofori-Kwakye
Kwabena Ofori-Kwakye
RJRaphael Johnson
Raphael Johnson
NKNoble Kuntworbe
Noble Kuntworbe
DODesmond Asamoah Bruce Otu
Desmond Asamoah Bruce Otu
YOYaa Asantewaa Osei
Yaa Asantewaa Osei
Developing countries face enormous challenges with substandard and falsified antimalarial drugs. One specific issue is the lack of a simple, cost-effective, and robust HPLC method to simultaneously determine and quantify the active pharmaceutical ingredients (APIs) in fixed-dose artemether-lumefantrine pharmaceutical dosage forms. The current study developed a novel, simple, sensitive, precise, accurate, and cost-effective RP-HPLC method for the simultaneous determination and quantification of artemether and lumefantrine in pharmaceutical dosage forms. The HPLC analysis was carried out on an Agilent 1260 Infinity Series HPLC system equipped with an ODS Intersil-C8 (150 × 4.6 mm) 5.0 µm column, by isocratic elution. The mobile phase composition consisted of acetonitrile and 0.05% orthophosphoric acid buffer of pH 3.5 in the ratio of 70 : 30 v/v. The analysis was performed at a 1 mL/min flow rate and a column temperature of 25°C. The total run time was 6 minutes. The detection was done with a variable wavelength detector (VWD) at an isosbestic point wavelength (λ) of 210 nm. The developed method was validated according to the ICH guidelines concerning system suitability, specificity, linearity, accuracy, precision, and robustness. The system suitability of the developed method revealed satisfactory theoretical plates and symmetry factors. The method proved to be specific, with no interference of mobile phase or excipients. The calibration plot exhibited linearity over the concentration range of 275–1925 μg/mL with = 0.9992 for artemether and a range of 150–1050 μg/mL with = 0.9985 for lumefantrine. The accuracy of the method, determined by the recovery study, was 99.79–100.16% for artemether and 99.04–99.50% for lumefantrine. The % RSD values for intraday precision were 0.175 and 0.203, while interday precision values were 0.340 and 0.554 for artemether and lumefantrine, respectively. The method demonstrated robustness when subjected to slight modifications in the flow rate, column temperature, and mobile phase composition. The developed analytical method proved satisfactory as per ICH guidelines and hence can be used for the determination and quantification of artemether and lumefantrine in bulk drug and pharmaceutical dosage forms.

11 May 2025 in medRxiv
Verified
Preprint
Open access
PDF file
JMJulius Caesar Mahama
Julius Caesar Mahama
DKDaphne Kleopa
Daphne Kleopa
PYPrince Kumi Yeboah
Prince Kumi Yeboah
SNSimon Nyarko
Simon Nyarko
The migration of healthcare professionals from low- and middle-income countries (LMICs) to high-income countries (HICs), often termed as brain drain, remains a significant and widely debated issue. This study examines the exodus of healthcare workers from Ghana and its impact on the country's health system. Using a scoping review methodology, we mapped and synthesized existing literature on migration of healthcare professionals from Ghana, focusing on key challenges and strategies to address this phenomenon. The Population, Concept, Context (PCC) framework was systematically applied to define study eligibility criteria. The search strategy employed Boolean operators (AND/OR) with key MeSH words including healthcare workforce, health policy, migration, brain drain, intervention strategies, and Ghana across databases such as PubMed, Google Scholar, Scopus, and Web of Science. Eleven (11) studies met the inclusion criteria. The review identified low wages, poor working conditions, limited career advancement opportunities, and political instability as primary drivers of healthcare migration of healthcare professionals. To mitigate these challenges, efforts should focus on improving domestic conditions for healthcare workers, including enhanced remuneration, better service conditions, and career development initiatives. Additionally, governments must prioritize strengthening healthcare infrastructure, particularly in rural regions, to reduce disparities in service delivery. The findings also suggest that partnerships with high-income countries could facilitate skills development programs for Ghanaian healthcare workers, provided such collaborations include strengthened agreements (e.g., bonding schemes) to ensure professionals return to apply their expertise domestically. While the scoping review synthesizes critical insights, further empirical studies targeting specific regions or demographic blocs are needed to assess whether migration trends have persisted or evolved. Future research should also explore new subpopulations, geographic contexts, or timeframes to evaluate the reproducibility of existing findings and their applicability to contemporary or shifting socioeconomic landscapes.

1 January 2025 in Journal of Parasitology Research
Verified
Journal Article
Open access
SOSamuel Ayetibo Ofori
Samuel Ayetibo Ofori
PAPapa Kofi Amissah-Reynolds
Papa Kofi Amissah-Reynolds
OGOpoku Gyamfi
Opoku Gyamfi
KAKofi Agyapong Addo
Kofi Agyapong Addo
SNSimon Nyarko
Simon Nyarko
EAEsther Ayemugah
Esther Ayemugah
Hookworm infections present a major health risk to dogs, especially in areas characterized by warmer climates and poor sanitation. This cross‐sectional study was undertaken to determine the prevalence of hookworm infections and the efficacy of anthelmintic treatments in dogs from the Bono East Region of Ghana. Four hundred and ninety‐one (491) canine stool samples were examined using the McMaster technique to ascertain the prevalence of hookworms. Using in vivo and in vitro techniques, the efficacy of three anthelmintics (albendazole, pyrantel, and niclosamide) was assessed in an experimental control trial involving dogs naturally infected with hookworms. The effects of the drugs on hematological and biochemical parameters were measured within a 14‐day period to assess changes over time. The study found a total prevalence of 54.2% (266), with significantly higher infection rates in puppies (69.8%, 97), hunting dogs (64.1%, 91), and rural dogs (84.2%, 160). Logistic regression identified age, purpose, and settlement type as risk factors for infection. Of the three treatments, niclosamide was the most efficacious, reducing egg counts by 95%, while albendazole was the least efficacious (−69%). In vitro tests confirmed the superior performance of niclosamide, with the lowest IC 50 value of 29.19 μ g/mL. Hookworm‐infected dogs exhibited anemia, eosinophilia, hypoalbuminemia, and hypoproteinemia. There was significant improvement in the hematobiochemical parameters after treatment, particularly in niclosamide‐treated dogs. Veterinarians can consider niclosamide, especially in resource‐limited settings, due to its affordability. The findings emphasize the importance of regular monitoring and treatment of hookworm infections to improve the overall health and well‐being of dogs in the region. Herein, we report for the first time on reduced efficacy of albendazole and pyrantel against dog‐related hookworms in Ghana.

16 March 2026 in Health Policy and Planning
Verified
Journal Article
Open access
SNSimon Nyarko
Simon Nyarko
RARoger A Atinga
Roger A Atinga
JMJulius Caesar Mahama
Julius Caesar Mahama
Sub-Saharan Africa (SSA) faces a dual opioid dilemma: widespread undertreatment of moderate to severe pain due to limited access to essential opioid analgesics, alongside increasing concern about misuse and diversion in selected contexts. Opioids are clinically indicated for severe cancer-related pain, advanced chronic illness, major trauma, surgery, and end-of-life care; yet, regional consumption remains disproportionately low relative to documented disease burden, indicating systemic under-provision rather than low need. This systematic review synthesizes evidence on opioid policy, regulation, access, and governance in SSA to examine how legal frameworks, institutional arrangements, political dynamics, and data systems shape medical availability. Following PRISMA and SWiM guidance, we reviewed peer-reviewed and gray literature addressing national drug control laws, regulatory implementation, procurement and supply systems, prescribing authority, and surveillance capacity; 33 studies met inclusion criteria. Across settings, restrictive or ambiguously interpreted legislation, multi-layered administrative controls, fragmented mandates across health and enforcement institutions, weak forecasting and distribution systems, concentrated prescribing authority, professional risk aversion, and chronic data gaps were consistently associated with constrained access. Concurrently, rising political and media attention to non-medical use, particularly of tramadol, has reinforced enforcement-oriented narratives that may further limit reform space. Persistent deficiencies in routine consumption data and unmet need assessment contribute to conservative import quotas and regulatory inertia. Addressing this imbalance requires proportionate, sequenced reform that strengthens data and forecasting systems, clarifies and aligns legal mandates with public health objectives, invests in workforce capacity and supply chains, and embeds safeguards against diversion while correcting avoidable under-treatment.